Article
Mutational analysis of the class I β‐tubulin gene in human breast cancer
25 Jul 2002
Abstract excerpt
Non-small cell lung cancers have a high incidence of somatic mutations of the beta-tubulin (class I) gene, suggesting involvement in the acquisition of resistance to taxanes, which exert their effects through binding to beta-tubulin. Since taxanes are often used in the treatment of breast cancer, we carried out a mutational analysis of the class I beta-tubulin (GenBank accession AF070600) gene in breast cancer....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
